Axert (Almotriptan Malate) - Summary

AXERT SUMMARY

AXERT^®
(almotriptan malate) Tablets

AXERT Tablets contain almotriptan malate, a selective 5-hydroxytryptamine_1B/1D(5-HT_1B/1D) receptor agonist.

AXERT Tablets are indicated for the acute treatment of migraine with or without aura in adults.

AXERT is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS). Safety and effectiveness of AXERT have not been established for cluster headache, which is present in an older, predominantly male population.

AXERT NEWS HIGHLIGHTS

Media Articles Related to Axert (Almotriptan)

Army Personnel Show Increased Risk For Migraine - Condition Underdiagnosed, Mistreated
Source: Headache / Migraine News From Medical News Today [2008.08.29]

Migraines Common in Stateside Military Officer Trainees
Source: MedPage Today Neurology [2008.08.29]

Health Tip: Managing Your Child's Migraines
Source: MedicineNet Chronic Pain Specialty [2008.08.08]

FDA Approves First Generic Divalproex Sodium To Treat Seizures, Migraine Headaches And Bipolar Disorder
Source: Bipolar News From Medical News Today [2008.08.01]

Gene May Put Women With Migraine At Increased Risk Of Heart Disease And Stroke
Source: Headache / Migraine News From Medical News Today [2008.07.31]

more>>

Published Studies Related to Axert (Almotriptan)

Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial. [2008.05.14]

Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan. [2008.04]

Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study). [2007.02]

Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. [2006.05]

Effect of food intake on the bioavailability of almotriptan, an antimigraine compound, in healthy volunteers: an open, randomized, crossover, single-dose clinical trial. [2006.04]

more>>

Clinical Trials Related to Axert (Almotriptan)

The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine Pain [Completed]

A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache [Completed]

A Study of 3 Dosage Strengths of Aalmotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents [Completed]

Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine [Completed]

Standardized sTudy With Almotriptan in eaRly Treatment of Migraine [Recruiting]

more>>